Editorial by LabNews Media LLC
Dear Readers,
Today marks the completion of an important transition for LabNews Media LLC: the full delisting and decommissioning of our former domain, lab-news.de. From this point forward, you will find all our content—past, present, and future—exclusively on labnews.io.
This is not merely a technical change, but the culmination of a deliberate decision made to safeguard the core principles that define our work: free, independent, and, when necessary, government-critical reporting.
As a U.S.-based company headquartered in New Mexico, LabNews Media LLC has always prioritized unfiltered, evidence-based journalism in the fields of life sciences, biotechnology, laboratory medicine, and digital health. For years, lab-news.de served as our primary platform, delivering bilingual content in English and German to a dedicated audience across Europe and beyond.
However, we have come to the conclusion that truly independent journalism—especially the kind that holds power to account and challenges official narratives—can no longer be reliably sustained within the European Union or Germany. Increasing regulatory pressures, threats of censorship, and an environment where critical voices are increasingly marginalized have made it clear that operating under an EU-based domain carries unacceptable risks to our editorial freedom.
By fully transitioning to the neutral, globally oriented .io domain—registered and protected under U.S. jurisdiction—we ensure that our reporting remains beyond the reach of such constraints. This move allows us to continue delivering rigorous coverage without compromise, whether on breakthroughs in oncology and genomics, the societal impacts of digital health technologies, or critical analyses of policy failures that affect public health and innovation.
The millions of legacy URLs from the old domain, including outdated translations, have now been permanently retired with a clear signal to search engines: they are gone for good. Our authentic archive and all new articles are preserved and thriving on labnews.io, where we continue to publish daily insights into the topics that matter most to the scientific community and the public.
We thank you, our readers, for your loyalty throughout this transition. Your support reinforces our commitment to truth and transparency. Please update your bookmarks, subscriptions, and RSS feeds to labnews.io—and join us there as we enter this new era of unrestricted independent journalism.
Freedom of information is more vital than ever. Together, we will protect it.
Sincerely,
The Editorial Team
LabNews Media LLC
New Mexico, USA
December 2025
